DaShenLin Pharmaceutical Group Co., Ltd. (SHA: 603233)

DaShenLin Pharmaceutical Group Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 21, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	17,424	28,359	37,585	33,307	51,603	27,171
Market Cap Growth	-35.23%	-24.55%	12.85%	-35.46%	89.92%	70.41%
Enterprise Value	20,279	31,251	40,044	35,732	49,307	25,680
Last Close Price	15.30	23.91	31.08	27.14	41.58	22.95
PE Ratio	20.43	24.31	36.29	42.10	48.58	38.67
Forward PE	17.74	23.76	31.37	28.06	49.98	33.98
PS Ratio	0.65	1.16	1.77	1.99	3.54	2.44
PB Ratio	2.54	3.57	5.48	5.61	9.26	6.27
P/TBV Ratio	13.62	14.61	11.71	11.90	14.49	9.36
P/FCF Ratio	11.71	20.59	13.81	128.08	44.42	22.52
P/OCF Ratio	5.79	8.94	10.01	21.42	26.41	15.91
PEG Ratio	1.92	1.92	1.92	1.92	1.92	2.40
EV/Sales Ratio	0.76	1.27	1.88	2.13	3.38	2.30
EV/EBITDA Ratio	7.22	15.50	22.15	27.36	32.16	24.25
EV/EBIT Ratio	14.71	17.40	25.18	32.45	36.19	28.03
EV/FCF Ratio	13.63	22.69	14.71	137.41	42.45	21.29
Debt / Equity Ratio	0.90	0.82	0.86	0.89	0.25	0.08
Debt / EBITDA Ratio	2.61	2.02	2.06	2.34	0.91	0.31
Debt / FCF Ratio	4.92	4.73	2.18	20.29	1.20	0.27
Asset Turnover	1.12	1.09	1.11	1.13	1.39	1.47
Inventory Turnover	4.13	3.92	3.53	3.29	3.80	3.43
Quick Ratio	0.56	0.54	0.62	0.55	0.93	0.80
Current Ratio	0.92	0.94	1.10	1.10	1.52	1.37
Return on Equity (ROE)	11.53%	16.63%	16.86%	13.98%	21.87%	18.78%
Return on Assets (ROA)	3.64%	4.99%	5.21%	4.64%	8.11%	7.53%
Return on Capital (ROIC)	5.96%	8.24%	8.28%	7.57%	14.64%	14.14%
Earnings Yield	4.89%	4.11%	2.76%	2.38%	2.06%	2.59%
FCF Yield	8.54%	4.86%	7.24%	0.78%	2.25%	4.44%
Dividend Yield	4.05%	1.30%	1.61%	1.28%	1.11%	1.26%
Payout Ratio	43.91%	51.82%	40.58%	67.53%	31.38%	36.06%
Buyback Yield / Dilution	0.25%	0.50%	-0.69%	0.24%	-2.65%	-2.13%
Total Shareholder Return	4.31%	1.79%	0.92%	1.51%	-1.53%	-0.87%

Source: S&P Capital IQ. Standard template. Financial Sources.